FMR LLC reports 6.1% stake in Manhattan Associates
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of the common stock of Manhattan Associates Inc. as of June 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of the common stock of Manhattan Associates Inc. as of June 30, 2026. FMR LLC reported beneficial ownership of 3,611,292.17 shares of common stock, representing 6.1% of the class, with sole dispositive power over these shares and sole voting power over 3,600,195.74 shares.
Abigail P. Johnson is also reported as a beneficial owner of the same 3,611,292.17 shares, representing 6.1% of the outstanding common stock, with sole dispositive power and no voting power. The filing notes that one or more other persons have rights to dividends or sale proceeds, including Select Technology Portfolio, whose interest amounted to 3,123,214.00 shares, or 5.3% of Manhattan Associates’ common stock as of June 30, 2026.
Key Figures
Key Terms
beneficially owned financial
Sole Voting Power financial
Sole Dispositive Power financial
Schedule 13G regulatory
parent holding company financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Manhattan Associates (MANH) does FMR LLC report owning?
What is the role of Select Technology Portfolio in Manhattan Associates (MANH) ownership?
Why was this Schedule 13G/A filed for Manhattan Associates (MANH)?
AI-generated analysis. How Rhea-AI works. Not financial advice.